Pages that link to "Item:Q2492935"
From MaRDI portal
The following pages link to On the efficiency of adaptive designs for flexible interim decisions in clinical trials (Q2492935):
Displaying 12 items.
- Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications (Q2875756) (← links)
- Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches (Q3078835) (← links)
- Benefit–Risk Evaluation of Multi-Stage Adaptive Designs (Q3155694) (← links)
- Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint (Q3391873) (← links)
- Are Flexible Designs Sound? (Q3436501) (← links)
- Group sequential designs using both type I and type II error probability spending functions (Q3842887) (← links)
- On the inefficiency of the adaptive design for monitoring clinical trials (Q4455417) (← links)
- Sample Size Re-Estimation Based on Two-Stage Analysis of Variance: Interim Analysis of Clinical Trials (Q4904676) (← links)
- A Regulatory View on Adaptive/Flexible Clinical Trial Design (Q5122841) (← links)
- Optimal promising zone designs (Q5208194) (← links)
- Sample size adaptation designs and efficiency comparison with group sequential designs (Q6618508) (← links)
- Optimal planning of adaptive two-stage designs (Q6628099) (← links)
